Levin Capital Strategies »

Silverback Therapeutics shares owned by Levin Capital Strategies

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Levin Capital Strategies from 13F filings

Historical chart of Levin Capital Strategies investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Levin Capital Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Levin Capital Strategies

Quarter filed Position value Share count Share price at filing
2023-12-31 $286k 52k 5.48
2023-09-30 $507k 134k 3.78
2023-06-30 $1.1M 169k 6.70
2023-03-31 $914k 140k 6.51
2022-12-31 $333k 39k 8.53